A carregar...

Strategic priorities for respiratory syncytial virus (RSV) vaccine development

Although RSV has been a high priority for vaccine development, efforts to develop a safe and effective vaccine have yet to lead to a licensed product. Clinical and epidemiologic features of RSV disease suggest there are at least 4 distinct target populations for vaccines, the RSV naïve young infant,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Anderson, L.J., Dormitzer, P.R., Nokes, D.J., Rappuoli, R., Roca, A., Graham, B.S.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3919153/
https://ncbi.nlm.nih.gov/pubmed/23598484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.11.106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!